GlassScriptPhysician profile
Alan M Nadour
NPI 1326178302
$8,377.08
in general payments reported to CMS, 2019-2025
15 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.85 · 2020: $33.04 · 2021: $34.18 · 2022: $12.79 · 2023: $7,634 · 2024: $307 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,500 · Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,500.00 |
| Food and Beverage | $767.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $7,500.00 | 2023 | Auryon Laser System 100-120 Vac |
| Bard Peripheral Vascular, INC. | $242.99 | 2023-2025 | Venclose Maven Catheter |
| Novo Nordisk INC | $196.81 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Becton, Dickinson and Company | $135.96 | 2024 | Venclose Maven Catheter |
| Lilly USA, LLC | $66.35 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Nevro Corp. | $53.09 | 2024 | Senza |
| Organogenesis INC. | $47.17 | 2023-2024 | Puraply |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.19 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $19.38 | 2021 | |
| Inspire Medical Systems, INC. | $17.97 | 2025 | Inspire |
| Medtronic USA, INC. | $17.51 | 2019 | |
| Exact Sciences Corporation | $17.08 | 2025 | Cologuard Collection Kit |
| Almirall LLC | $14.80 | 2021 | |
| Dermira, INC. | $14.44 | 2020 | |
| Smith+Nephew, INC. | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Nadour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.